Results 91 to 100 of about 69,334 (300)

Current status and future strategies of chimeric antigen receptor T-cells in the treatment of pancreatic cancer

open access: yesZhongguo aizheng zazhi, 2019
Chimeric antigen receptor (CAR) T-cells have recently provided promising advances as a novel immunotherapeutic approach for cancer treatment especially in B-cell malignancies.
潘泽雁, 湛先保
doaj  

Adverse events of vaccines and the consequences of non-vaccination: a critical review

open access: yesRevista de Saúde Pública, 2018
OBJECTIVE: To analyze the risks related to vaccines and the impacts of non-vaccination on the world population. METHODS: This is a narrative review that has considered information present in the bibliographic databases NCBI-PubMed, Medline, Lilacs, and ...
Luana Raposo de Melo Moraes Aps   +5 more
doaj   +1 more source

The effect of adjuvants on immunization of the Nile tilapia, oreochromis niloticus with aeromonas hydrophila bacterin

open access: yes, 1997
The effects of adjuvants on the immune response of the Nile tilapia, Greochromis niloticus when injected intraperitoneally (UP) I, 4, 7 and 10 weeks post immunization with the bacterin prepared from Aeromonas hydrophila have been investigated.
Ali, Hekmat M.
core  

Biodegradable Acoustic Targeting for Ultrasound‐Supported Gene Therapy (BATUS) in Glioblastoma

open access: yesAdvanced Science, EarlyView.
ABSTRACT Glioblastoma (GBM) remains one of the most challenging brain malignancies due to the restrictive nature of the blood–brain barrier (BBB), which severely limits effective drug and gene delivery. To overcome this, we introduce Biodegradable Acoustic Targeting for Ultrasound‐Supported Gene Therapy (BATUS), a modular platform that enables safe ...
Gulsah Erel‐Akbaba   +25 more
wiley   +1 more source

Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report

open access: yesToxins
Botulinum Neurotoxin A (BoNT/A) is a bacterial protein that has proven to be a valuable pharmaceutical in therapeutic indications and aesthetic medicine.
Michael Uwe Martin   +2 more
doaj   +1 more source

Autoantigen mRNA‐LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity

open access: yesAdvanced Science, EarlyView.
Systemic and intramuscular delivery of autoantigen mRNA via lipid nanoparticles reprograms antigen‐presenting cells toward a mature, homeostatic state, driving antigen‐specific T cell exhaustion and providing therapeutic efficacy across autoimmune disease models.
Paulien Baeten   +30 more
wiley   +1 more source

Cell Immunol [PDF]

open access: yes
Avian H7N9 influenza virus infection with fatal outcomes continues to pose a pandemic threat and highly immunogenic vaccines are urgently needed. In this report we show that baculovirus-derived recombinant H7 hemagglutinin protein, when delivered with ...

core  

The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.

open access: yes, 2010
<p>The development of safe, novel strong adjuvants is necessary to maximize the efficacy of and the immune response induced by new and/or available vaccines administered through the mucosal route to chickens. Chitosan is a non-toxic, biocompatible,
Y. Gardin   +15 more
core   +1 more source

Cerium Nanoparticle‐Mediated Inhibition of the NSUN2/m5C Axis Suppresses Synovial Aggression in Rheumatoid Arthritis

open access: yesAdvanced Science, EarlyView.
A novel epitranscriptomic mechanism in rheumatoid arthritis is uncovered: NSUN2 promotes disease via m5C‐dependent stabilization of ICMT mRNA, fueling the migration and invasion of pathogenic RA FLS. Targeting this axis with engineered nanoparticles (Ce/SAA NPs) effectively inhibits disease progression, presenting a precise therapeutic strategy ...
Ruiru Li   +15 more
wiley   +1 more source

Mucosal adjuvants

open access: yes, 2010
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of
Harandi, Ali M,, Medaglini, Donata
core   +2 more sources

Home - About - Disclaimer - Privacy